“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

Adults as young as 50 may now qualify for an respiratory synctial virus vaccine if they have certain health conditions.

GSK has applied to the US Food and Drug Administration (FDA) to extend use of its respiratory syncytial virus (RSV) vaccine Arexvy to adults under the age of 50 who are at increased risk of the ...

FDA accepts GSK's filing to extend Arexvy's RSV vaccine use to high-risk adults under 50, with a decision due in 2026.

One major reason why the U.S. and Western Europe have seen dramatic population increase over the last 200-plus years, Aaby ...

The update covers the safety and appropriate timing of vaccinations, screening for osteoporosis, cervical cancer, skin cancer ...

Moderna stock has faced heavy pressure from negative headlines, regulatory setbacks and political uncertainty. See why I ...

Six in 10 U.S. adults think that AI-generated health information is somewhat or very reliable, a survey from the Annenberg Public Policy Center finds. But nearly half (49%) are not comfortable with ...

If I have sounded like a broken record these past months, it is because these developments in American public health are as ...

The Centers for Disease Control and Prevention (CDC) recommends that pregnant women receive an RSV vaccine during their third ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...